Biotheryx (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- July 28, 2020
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founders
- David Stirling, Ph.D.
- Company Description
- Biotheryx is a clinical-stage biopharmaceutical company that focuses on the development of protein degrader therapies
- Market
- Clinical-stage biopharmaceuticals for life-threatening diseases
- Location
- San Diego, CA, USA
- Coinvestors
- MSD Partners